Orient Europharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
February 26, 2021 at 01:52 am IST
Share
Orient EuroPharma Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 5,383.657 million compared to TWD 6,093.253 million a year ago. Operating income was TWD 117.711 million compared to TWD 336.411 million a year ago. Net income was TWD 199.303 million compared to TWD 247.664 million a year ago. Basic earnings per share was TWD 2.3 compared to TWD 2.86 a year ago. Diluted earnings per share was TWD 2.29 compared to TWD 2.84 a year ago.
Orient Europharma Co., Ltd. is principally engaged in the manufacture and distribution of nutritious healthcare products and medical cosmetic products, as well as western drugs. The Company operates nutritious healthcare products and medical cosmetic products segment, providing infant milk powders, nutritious products and functional healthcare products, as well as dermatological preparations, medical hair care series, organic skin care series and medical make-up products, among others; western drugs segment, providing products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases and asthma, among others.
ORIENT EUROPHARMA CO., LTD. 
